Advanced search
Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 3, 2018 - Issue 3
Submit an article Journal homepage
646
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Interrogating the enhancer landscape of intracranial ependymomas: perspectives for precision medicine

Konstantin OkonechnikovHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, GermanyView further author information
,
Stephen C. MackDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USAView further author information
,
Marcel KoolHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, GermanyView further author information
,
Stefan M. PfisterHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany;Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, GermanyView further author information
&
Kristian W. PajtlerHopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany;Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, GermanyCorrespondence[email protected]
View further author information
Pages 147-149 | Received 06 Mar 2018, Accepted 17 Apr 2018, Published online: 25 Apr 2018

References

  • Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.
  • Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):35–47.
  • Ellison DW, Kocak M, Figarella-Branger D, et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negat Results Biomed. 2011;10(1):7.
  • Pajtler KW, Mack SC, Ramaswamy V, et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathol. 2017;133(1):5–12.
  • Parker M, Mohankumar KM, Punchihewa C, et al. C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature. 2014;506(7489):451.
  • Pajtler KW, Witt H, Sill M, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27(5):728–743.
  • Pennacchio LA, Bickmore W, Dean A, et al. Enhancers: five essential questions. Nat Rev Genet. 2013;14(4):288.
  • Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell. 2011;144(3):327–339.
  • Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947.
  • Northcott PA, Lee C, Zichner T, et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature. 2014;511(7510):428.
  • Zimmerman MW, Liu Y, He S, et al. c-MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification. Cancer Discov. 2018;8(3):320-335.
  • Lin CY, Erkek S, Tong Y, et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature. 2016;530(7588):57.
  • Liu F, Hon GC, Villa GR, et al. EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling. Mol Cell. 2015;60(2):307–318.
  • Mack SC, Pajtler KW, Chavez L, et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature. 2018;553(7686):101. ••Enhancers landscape is uncovered in ependymoma. 
  • Griffith M, Griffith OL, Coffman AC, et al. DGIdb: mining the druggable genome. Nat Methods. 2013;10(12):1209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.